Humacyte, Inc.
HUMANasdaqCIK 1818382HealthcareFiscal year ends Dec 31
Reports and events: 138 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-10-0710:06 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-106404 |
| 2024-09-2521:47 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-102498 |
| 2024-09-0320:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-24-000173 |
| 2024-08-1320:47 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001818382-24-000156 |
| 2024-08-1311:04 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000153 |
| 2024-07-3120:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000146 |
| 2024-06-1320:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001818382-24-000102 |
| 2024-06-0423:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-24-000085 |
| 2024-05-1320:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001818382-24-000056 |
| 2024-05-1011:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-24-000054 |
| 2024-04-2911:12 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001818382-24-000047 |
| 2024-03-2812:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001818382-24-000040 |
| 2024-03-2211:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-24-000034 |
| 2024-03-0821:03 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-24-000029 |
| 2024-03-0720:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-031844 |
| 2024-03-0411:53 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818382-24-000026 |
| 2024-02-2921:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000019 |
| 2024-02-0913:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000005 |
| 2023-12-1213:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-23-000177 |
| 2023-12-0115:50 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-122668 |
| 2023-11-0921:28 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001818382-23-000162 |
| 2023-11-0921:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-23-000160 |
| 2023-09-1520:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-23-000131 |
| 2023-09-1211:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-23-000125 |
| 2023-08-2222:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-23-000122 |
| 2023-08-1412:44 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001818382-23-000114 |
| 2023-08-1411:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-23-000112 |
| 2023-07-2612:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-23-000104 |
| 2023-06-1520:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-23-000050 |
| 2023-06-0820:06 ET | 8-K | 5.07 Shareholder vote results | 0001818382-23-000037 |
| 2023-05-2621:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-065548 |
| 2023-05-1220:18 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001818382-23-000030 |
| 2023-05-1211:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-23-000028 |
| 2023-04-2810:42 ET | DEF 14A | Proxy statementPeriod 2023-06-07 | 0001818382-23-000021 |
| 2023-03-2412:49 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001818382-23-000016 |
| 2023-03-2411:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-23-000014 |
| 2023-03-1312:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001818382-23-000007 |
| 2022-12-1221:04 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001818382-22-000195 |
| 2022-11-1013:56 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001818382-22-000180 |
| 2022-11-1012:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-22-000179 |
| 2022-09-2020:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818382-22-000172 |
| 2022-09-1920:39 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-22-000163 |
| 2022-08-1212:49 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001818382-22-000105 |
| 2022-08-1211:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-22-000103 |
| 2022-06-1320:05 ET | 8-K | 5.07 Shareholder vote results | 0001818382-22-000071 |
| 2022-05-1312:46 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001818382-22-000039 |
| 2022-05-1311:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-22-000037 |
| 2022-04-2910:41 ET | DEF 14A | Proxy statementPeriod 2022-06-09 | 0001818382-22-000028 |
| 2022-03-2920:13 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001818382-22-000011 |
| 2022-03-2911:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-22-000009 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.